TCM product approved for sale in Singapore
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Xizang's remote villages gain access to express delivery services
- Egyptian man explores 460-year-old fair in Tianjin
- 10,000-ton electric container ship tests off Jiangxi province
- China's construction sector sees drop in energy use, emissions during build phase, rise in operations
- Guangdong sees surge in holiday arrivals as travel pattern shifts
- International commercial court established in Guangzhou
































